特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
949549

二分脊椎症治療の世界市場(2019年~2025年)

Spina Bifida Treatment Market 2019-2025

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.45円
二分脊椎症治療の世界市場(2019年~2025年)
出版日: 2020年06月08日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

乳幼児の疾患の増加と医療の進歩が、世界の二分脊椎症治療市場の成長を牽引しています。さらには意識の高まり、政府の支援の増加、資金調達と償還の増加により、当市場の成長が促進されています。

世界の二分脊椎症治療市場は、タイプと治療法に基づいて分割されています。タイプ別では、市場は潜在性、閉鎖神経管欠損、髄膜瘤、および脊髄髄膜瘤に分割されます。そして治療法別では、市場は手術、医療処置、およびデバイスに分割されます。手術に基づく分類には、市場はさらに帝王切開、 恥骨上膀胱瘻造設術、脊椎手術、人工肛門などに分割されます。医療処置に基づく分類では、市場は尿路カテーテル法、尿路変更、浣腸に分割されています。

地域的には、市場は北米、欧州、アジア太平洋、およびその他の地域(RoW)を含む4つの主要な地域に分類されます。 北米は、 世界の二分脊椎症治療市場で大きな市場シェアを持つと予想されています。アジア太平洋地域は、患者数の多さと健康への意識の高まりにより、最も急速に成長している二分脊椎症治療の市場です。さらに、政府が後押しする啓蒙活動、政府の支援の増加、資金調達と償還の増加により、市場の成長が促進されています。

Medtronic PLC、Boston Scientific Corp.、Karl Storz SE&Co. KG、Johnson&Johnson Service Inc.、Zimmer Biomet Holdings Inc.、NuVasive Inc.、Smith&Nephew PLC、Stryker CorpおよびWellspect Healthcare(A Dentsply Sirona Company)などが二分脊椎症治療を提供する主要企業です。市場プレーヤーが世界の規模での競争力を高めるために採用する戦略には、合弁事業や製品の発売が含まれます。

当レポートでは世界の二分脊椎症治療市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、タイプ・治療法・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイル、市場機会など、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向

第3章 競合情勢

  • 会社シェア分析
  • 主要戦略分析
  • 主要企業分析
    • Medtronic PLC
    • Boston Scientific Corp.
    • Karl Storz SE&Co. KG
    • Johnson&Johnson Service、Inc.
    • Zimmer Biomet Holdings、Inc.

第4章 市場決定要因

  • 動機
  • 抑制要因
  • 市場機会

第5章 市場セグメンテーション

  • タイプ別
    • 潜在性
    • 閉鎖神経管欠損
    • 髄膜瘤
    • 脊髄髄膜瘤
  • 治療法別
    • 手術
    • 医療処置
    • デバイス

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • その他アジア太平洋地域
  • その他の地域

第7章 企業プロファイル

  • B. Braun Melsungen AG
  • Boston Scientific Corp.
  • C.R. Bard, Inc. (Becton, Dickinson and Co.)
  • Coloplast A/S
  • ConvaTec Group PLC
  • Cook Medical, Inc.
  • Johnson & Johnson Service, Inc.
  • Karl Storz SE & Co. KG
  • Medtronic PLC
  • NuVasive, Inc.
  • Smith & Nephew PLC
  • Stryker Corp.
  • Teleflex, Inc.
  • Wellspect Healthcare (A Dentsply Sirona Company)
  • Zimmer Biomet Holdings, Inc.
図表

LIST OF TABLES

  • 1. GLOBAL SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 2. GLOBAL OCCULTA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL CLOSED NEURAL TUBE DEFECTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL MENINGOCELE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL MYELOMENINGOCELE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 7. GLOBAL SPINA BIFIDA SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL CESAREAN SECTION SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL SUPRAPUBIC CYSTOSTOMY SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL SPINAL SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL COLOSTOMY SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 12. GLOBAL OTHER SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 13. GLOBAL MEDICAL PROCEDURE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 14. GLOBAL URINARY CATHETERIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 15. GLOBAL URINARY DIVERSION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 16. GLOBAL ENEMA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 17. GLOBAL SPINA BIFIDA DEVICE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 18. GLOBAL SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 19. NORTH AMERICAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 20. NORTH AMERICAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 21. NORTH AMERICAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 22. EUROPEAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 23. EUROPEAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 24. EUROPEAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 25. ASIA-PACIFIC SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 26. ASIA-PACIFIC SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 27. ASIA-PACIFIC SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 28. REST OF THE WORLD SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 29. REST OF THE WORLD SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SPINA BIFIDA TREATMENT MARKET SHARE BY TYPE, 2018 VS 2025 (%)
  • 2. GLOBAL SPINA BIFIDA TREATMENT MARKET SHARE BY TREATMENT, 2018 VS 2025 (%)
  • 3. GLOBAL SPINA BIFIDA TREATMENT MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. ROE SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
目次
Product Code: OMR2021868

Global Spina Bifida Treatment Market Size, Share & Trends Analysis Report, by Type (Occulta, Closed neural tube defects, Meningocele, and Myelomeningocele), by Treatment (Surgery {Cesarean section, Suprapubic cystostomy, Spinal Surgery, Colostomy, and Others}, Medical Procedure {Urinary catheterization, Urinary diversion, Enema}, and Devices) and Forecast Period 2019-2025

The global spina bifida treatment market is estimated to grow at a CAGR during the forecast period. Growing cases of spina bifida among the infants and medical advancement are driving the growth of the global spina bifida treatment market. Moreover, growing awareness, increasing government assistance, and rising funding and reimbursement are propelling the growth of the global spina bifida market.

The global spina bifida treatment market is segmented based on type and treatment. Based on the type, the market is segmented into occulta, closed neural tube defects, meningocele, and myelomeningocele. And based on the treatment, the market is segmented into surgery, medical procedures, and devices. Furthermore, based on the surgery, the market is further segmented into the cesarean section, suprapubic cystostomy, spinal surgery, colostomy, and others. Based on the medical procedure, the market is segmented into urinary catheterization, urinary diversion, enema.

Based on geography, the market is classified into four major regions, including North America, Europe, Asia-Pacific, and RoW. North America is expected to have a significant market share in the global spina bifida treatment market. Asia-Pacific region is the fastest-growing spina bifida treatment market owing to large numbers of the patient and increasing health awareness. Moreover, growing government-sponsored awareness, increasing government assistance, and rising funding and reimbursement are propelling the growth of the market.

The key players providing spina bifida treatment that includeMedtronic PLC, Boston Scientific Corp., Karl Storz SE & Co. KG, Johnson & Johnson Service, Inc., Zimmer Biomet Holdings, Inc., NuVasive, Inc, Smith & Nephew PLC, Stryker Corp., and Wellspect Healthcare (A Dentsply Sirona Company).The strategies adopted by the market players include joint venture and product launches, to increase their competitiveness across a global scale.

Research Methodology

The market study of the global spina bifida treatmentmarket is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

  • Reports of companies involved in the market
  • Authentic Public Databases
  • Whitepapers such as research papers and news blogs
  • Company websites and their product catalog

The report is intended for providers, suppliers, and distributors of fiberglass, for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and will serve as a source for 360-degree analysis of the market.

Market Segmentation-

  • Global Spina Bifida TreatmentMarket Research and Analysis by Type
  • Global Spina Bifida TreatmentMarket Research and Analysis by Treatment

The Report Covers:

  • Comprehensive research methodology of the global spina bifida treatmentmarket.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Insights about market determinants which are stimulating the global spina bifida treatment market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusions

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Medtronic PLC
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Boston Scientific Corp.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Karl Storz SE & Co. KG
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Johnson & Johnson Service, Inc.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Zimmer Biomet Holdings, Inc.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Spina Bifida Treatment Marketby Type
    • 5.1.1. Occulta
    • 5.1.2. Closed neural tube defects
    • 5.1.3. Meningocele
    • 5.1.4. Myelomeningocele
  • 5.2. Global Spina Bifida Treatment Marketby Treatment
    • 5.2.1. Surgery
      • 5.2.1.1. Cesarean section
      • 5.2.1.2. Suprapubic cystostomy
      • 5.2.1.3. Spinal Surgery
      • 5.2.1.4. Colostomy
      • 5.2.1.5. Others
    • 5.2.2. Medical Procedure
      • 5.2.2.1. Urinary Catheterization
      • 5.2.2.2. Urinary Diversion
      • 5.2.2.3. Enema
    • 5.2.3. Devices

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. B. Braun Melsungen AG
  • 7.2. Boston Scientific Corp.
  • 7.3. C.R. Bard, Inc. (Becton, Dickinson and Co.)
  • 7.4. Coloplast A/S
  • 7.5. ConvaTec Group PLC
  • 7.6. Cook Medical, Inc.
  • 7.7. Johnson & Johnson Service, Inc.
  • 7.8. Karl Storz SE & Co. KG
  • 7.9. Medtronic PLC
  • 7.10. NuVasive, Inc.
  • 7.11. Smith & Nephew PLC
  • 7.12. Stryker Corp.
  • 7.13. Teleflex, Inc.
  • 7.14. Wellspect Healthcare (A Dentsply Sirona Company)
  • 7.15. Zimmer Biomet Holdings, Inc.
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.